journal article·2026-07-21Open access

Resolving Heterogeneity of Targeted Lipid Nanoparticles Through Solution‐Based Biophysical Analyses

Hannah C. Geisler, Hannah C. Safford, Ajay S. Thatte, Marshall S. Padilla, Elisa Battistini, Hannah M. Yamagata, Violet M. Ullman, Alex Chan, Benjamin E. Nachod, Anushka Agrawal, Maxwell B. Watkins, Jesse B. Hopkins, Andrew Tsourkas, Kushol Gupta, Michael J. Mitchell

Abstract

ABSTRACT Targeted lipid nanoparticles (tLNPs) enable cell‐specific nucleic acid delivery through covalent attachment of targeting ligands that drive receptor‐mediated LNP uptake. tLNPs are potentially promising for pregnancy‑associated applications where precise delivery is required to minimize maternal toxicity and protect fetal health. Yet, rational tLNP design is limited by an incomplete understanding of how physicochemical properties influence biological performance. Traditional analytical methods report only ensemble‐averaged properties, leaving the nanoscale heterogeneity of tLNPs unresolved. Here, we utilize asymmetric flow field‐flow fractionation integrated with in‐line UV spectral analysis, light scattering, and synchrotron small‐angle X‐ray scattering (AF4‐UV‐DLS‐MALS‐SAXS) to resolve ligand‐dependent tLNP subpopulations that differ in size, shape, composition, and relative abundance. Protein conjugation preserves the internal lipid–RNA nanostructure of base LNPs but substantially increases particle heterogeneity, particularly for larger and multivalent ligands. Despite increased heterogeneity, tLNPs functionalized with higher‐avidity ligands achieve more effective targeted placental RNA delivery in mice. Chemometric SAXS analyses reveal that only SAXS‐resolved tLNP subpopulations, not ensemble‐averaged parameters, correlate with targeted placental transfection in vivo, whereas bulk physicochemical metrics more strongly associate with nonspecific hepatic delivery. Together, this work harnesses a separation‐coupled biophysical platform to resolve previously inaccessible tLNP subpopulations and provides insights to inform rational engineering of next‐generation targeted RNA therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Field-Flow Fractionation Techniques · Ultrasound and Hyperthermia Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering University of Pennsylvania Philadelphia Pennsylvania USA

The Biophysics Collaborative Access Team (BioCAT) Department of Physics Illinois Institute of Technology Chicago Illinois USA

Department of Biochemistry and Biophysics Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Penn Institute for RNA Innovation University of Pennsylvania Philadelphia Pennsylvania USA

Abramson Cancer Center Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Institute for Immunology Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Cardiovascular Institute Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Funding

National Institutes of Health · Burroughs Wellcome Fund · National Science Foundation Graduate Research Fellowship Program · National Institute of General Medical Sciences

References (88)

Show source-provided references
1. 10.1038/s41573‐020‐0090‐810.1038/s41573‐020‐0090‐8 ↗
2. 10.1038/s41578‐021‐00358‐010.1038/s41578‐021‐00358‐0 ↗
3. 10.1038/s41591‐022‐02061‐110.1038/s41591‐022‐02061‐1 ↗
4. 10.1021/acsnano.4c0234110.1021/acsnano.4c02341 ↗
5. 10.1021/acs.analchem.4c0003110.1021/acs.analchem.4c00031 ↗
6. 10.1007/s00249‐023‐01663‐y10.1007/s00249‐023‐01663‐y ↗
7. 10.1101/2025.10.17.68313010.1101/2025.10.17.683130 ↗
8. 10.1021/acs.molpharmaceut.0c0085710.1021/acs.molpharmaceut.0c00857 ↗
9. 10.1039/D5NH00432B10.1039/D5NH00432B ↗
10. 10.1126/science.ads847310.1126/science.ads8473 ↗
11. 10.1002/smll.20230437810.1002/smll.202304378 ↗
12. 10.1126/sciadv.abc945010.1126/sciadv.abc9450 ↗
13. 10.1126/sciadv.abj690110.1126/sciadv.abj6901 ↗
14. 10.1016/j.celrep.2018.02.01410.1016/j.celrep.2018.02.014 ↗
15. 10.1021/acs.nanolett.3c0030410.1021/acs.nanolett.3c00304 ↗
16. 10.1038/s44222‐023‐00040‐w10.1038/s44222‐023‐00040‐w ↗
17. 10.1038/s41586‐024‐08291‐210.1038/s41586‐024‐08291‐2 ↗
18. 10.1093/humupd/dmaa04910.1093/humupd/dmaa049 ↗
19. 10.1038/s41587‐023‐01825‐510.1038/s41587‐023‐01825‐5 ↗
20. 10.3390/pharmaceutics1304054910.3390/pharmaceutics13040549 ↗
21. 10.1038/s41598‐023‐42274‐z10.1038/s41598‐023‐42274‐z ↗
22. 10.1016/j.ijpharm.2024.12494010.1016/j.ijpharm.2024.124940 ↗
23. 10.1016/j.ejpb.2024.11423510.1016/j.ejpb.2024.114235 ↗
24. 10.1038/s41587‐025‐02855‐x10.1038/s41587‐025‐02855‐x ↗
25. 10.1016/j.mtadv.2022.10029910.1016/j.mtadv.2022.100299 ↗
26. 10.1021/cr300143v10.1021/cr300143v ↗
27. 10.1007/s00216‐023‐04900‐710.1007/s00216‐023‐04900‐7 ↗
28. 10.1107/S160057752500395910.1107/S1600577525003959 ↗
29. 10.1021/acs.analchem.5c0591110.1021/acs.analchem.5c05911 ↗
30. 10.64898/2026.01.16.69968310.64898/2026.01.16.699683 ↗
31. E.Bittrich S.Boye Z. V.Niekerk et al. “Structural Profiling of Lipid Nanoparticles at Sub‐10 Nm Resolution via Online AF4 Coupled to SAXS and SANS ”ChemXriv(2025) https://doi.org/10.26434/chemrxiv‐2025‐6mtt8‐v2.10.26434/chemrxiv-2025-6mtt8-v2 ↗
32. 10.1016/S0140‐6736(20)32335‐710.1016/S0140‐6736(20)32335‐7 ↗
33. 10.1002/smll.20230085210.1002/smll.202300852 ↗
34. 10.1021/ja301621z10.1021/ja301621z ↗
35. 10.1021/acs.nanolett.1c0135310.1021/acs.nanolett.1c01353 ↗
36. 10.1021/jacs.2c1289310.1021/jacs.2c12893 ↗
37. 10.1021/ja044996f10.1021/ja044996f ↗
38. 10.1016/j.jconrel.2024.05.03610.1016/j.jconrel.2024.05.036 ↗
39. 10.1038/s41596‐025‐01330‐w10.1038/s41596‐025‐01330‐w ↗
40. 10.1126/science.126041910.1126/science.1260419 ↗
41. 10.1016/j.jchromb.2021.12301510.1016/j.jchromb.2021.123015 ↗
42. 10.3791/5961510.3791/59615 ↗
43. The Reflection of X‐Rays by Crystals
44. 10.1038/s42003‐021‐02441‐210.1038/s42003‐021‐02441‐2 ↗
45. 10.1021/acsnano.3c0118610.1021/acsnano.3c01186 ↗
46. 10.1107/S002188988708709010.1107/S0021889887087090 ↗
47. 10.1016/j.jconrel.2025.11384810.1016/j.jconrel.2025.113848 ↗
48. 10.3390/cryst903016010.3390/cryst9030160 ↗
49. 10.1007/978-3-662-39778-7_1010.1007/978-3-662-39778-7_10 ↗
50. Malinowski E. R. · 2002
51. 10.1021/jacs.6b0156310.1021/jacs.6b01563 ↗
52. 10.1107/S205225252100055510.1107/S2052252521000555 ↗
53. 10.1038/nmeth.245310.1038/nmeth.2453 ↗
54. 10.1107/S002188981001577310.1107/S0021889810015773 ↗
55. 10.1038/s43586‐021‐00064‐910.1038/s43586‐021‐00064‐9 ↗
56. Pilz I. · 1979 · 148
57. 10.1007/s11095‐024‐03671‐910.1007/s11095‐024‐03671‐9 ↗
58. 10.1107/S090744491104979110.1107/S0907444911049791 ↗
59. 10.3390/ph703031110.3390/ph7030311 ↗
60. 10.7554/eLife.6026610.7554/eLife.60266 ↗
61. 10.1530/JME‐22‐010510.1530/JME‐22‐0105 ↗
62. 10.1038/nnano.2007.7010.1038/nnano.2007.70 ↗
63. 10.1021/ar300031y10.1021/ar300031y ↗
64. 10.1021/nn301282m10.1021/nn301282m ↗
65. 10.1038/s41467‐020‐14527‐210.1038/s41467‐020‐14527‐2 ↗
66. 10.1073/pnas.060099710310.1073/pnas.0600997103 ↗
67. 10.1016/j.jconrel.2023.07.02010.1016/j.jconrel.2023.07.020 ↗
68. 10.1038/s41467‐022‐33157‐410.1038/s41467‐022‐33157‐4 ↗
69. 10.1016/j.nano.2012.05.01510.1016/j.nano.2012.05.015 ↗
70. 10.1002/anie.20050279410.1002/anie.200502794 ↗
71. 10.1002/(SICI)1521‐3773(19981102)37:20<2754::AID‐ANIE2754>3.0.CO;2‐310.1002/(SICI)1521‐3773(19981102)37:20<2754::AID‐ANIE2754>3.0.CO;2‐3 ↗
72. 10.1007/s00262‐006‐0180‐410.1007/s00262‐006‐0180‐4 ↗
73. 10.1016/j.jmb.2008.07.08510.1016/j.jmb.2008.07.085 ↗
74. 10.1021/acs.molpharmaceut.1c0079810.1021/acs.molpharmaceut.1c00798 ↗
75. 10.1107/S160057752000236210.1107/S1600577520002362 ↗
76. 10.1016/S0006‐3495(00)76713‐010.1016/S0006‐3495(00)76713‐0 ↗
77. 10.1107/S090904950401676010.1107/S0909049504016760 ↗
78. 10.1107/S205979831601717410.1107/S2059798316017174 ↗
79. 10.1107/S160057672301101910.1107/S1600576723011019 ↗
80. 10.6028/jres.124.01810.6028/jres.124.018 ↗
81. 10.1016/0169-7439(95)00047-X10.1016/0169-7439(95)00047-X ↗
82. 10.1107/S160057671701143810.1107/S1600576717011438 ↗
83. 10.1107/S002188989200166310.1107/S0021889892001663 ↗
84. 10.1007/978-1-4757-6624-010.1007/978-1-4757-6624-0 ↗
85. 10.1107/S002188989100340010.1107/S0021889891003400 ↗
86. 10.1002/polb.2096710.1002/polb.20967 ↗
87. 10.1038/nature1207010.1038/nature12070 ↗
88. 10.1038/nmeth.458110.1038/nmeth.4581 ↗